SANDRA MARSHALL: Open Payments
NPI 1992438998 · NORTH WILKESBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$862 in 53 payments from 17 companies in 2025. Trend: 2023 $953 · 2024 $1,319 · 2025 $862
Food & beverage: $862
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $227 |
| AstraZeneca Pharmaceuticals LP | 9 | $185 |
| Otsuka America Pharmaceutical, Inc. | 4 | $94 |
| Novo Nordisk Inc | 3 | $51 |
| SHIELD THERAPEUTICS INC | 3 | $51 |
| Axsome Therapeutics, Inc. | 1 | $30 |
| Forte Bio-Pharma LLC | 1 | $27 |
| Dexcom, Inc. | 1 | $25 |
| SCILEX PHARMACEUTICALS INC. | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $23 |
Products named: VRAYLAR, BREZTRI, REXULTI, ACCRUFER, QULIPTA, AIRSUPRA, Symbravo, Wegovy.
Industry payments across NC — which companies pay providers there.
